TA
ENTL icon

Tamarack Advisers’s Entellus Medical, Inc. Common Stock ENTL Stock Holding History

Tamarack Advisers’s Portfolio ENTL Stock Details ENTL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-45,837
Closed -$633K – 42
2017
Q1 		$633K Buy
+45,837
New +$736K 0.4% 28

Other funds holding ENTL

EWM
Essex Woodlands Management The Woodlands, Texas $254M AUM 4.59% 1-Year Est. Return
SHI
SV Health Investors Boston, Massachusetts $32.3M AUM 20.15% 1-Year Est. Return
DGI
Discovery Group I Chicago, Illinois $262M AUM 29.24% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
Frontier Capital Management
Frontier Capital Management Boston, Massachusetts $10.7B AUM 67.78% 1-Year Est. Return
ArrowMark Colorado Holdings
ArrowMark Colorado Holdings Denver, Colorado $2.4B AUM 42.85% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Tamarack Advisers's ENTL Position: Q2 2017 in Review

Tamarack Advisers sold out of Entellus Medical, Inc. Common Stock (ENTL) in Q2 2017, closing a stake of 45,837 shares — an estimated $633K sold.

Tamarack Advisers first reported a position in ENTL in Q1 2017 and held it in 1 quarter. The position peaked at $633K in Q1 2017. 73 funds tracked by Wall St. Rank hold ENTL as of Q2 2017.

  • Tamarack Advisers reported no remaining Entellus Medical, Inc. Common Stock position as of Q2 2017 after selling out during the quarter.
  • Tamarack Advisers sold 45,837 Entellus Medical, Inc. Common Stock shares in Q2 2017, an estimated $633K.
  • Tamarack Advisers first reported a position in Entellus Medical, Inc. Common Stock in Q1 2017 and held it in 1 quarter.
  • Tamarack Advisers's Entellus Medical, Inc. Common Stock position peaked at $633K in Q1 2017.
  • 73 funds tracked by Wall St. Rank held Entellus Medical, Inc. Common Stock as of Q2 2017.

Based on Tamarack Advisers's 13F filing for Q2 2017, filed 8 Aug 2017.